Trials / Not Yet Recruiting
Not Yet RecruitingNCT06906978
Single Cell Acute Leukemia Analysis
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Assistance Publique Hopitaux De Marseille · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Numerous chemotherapy and immunotherapy resistance genes have been identified in cancers in general and acute myeloid leukemia in particular. As a preliminary to this study, the investigators hypothesized the co-expression of these genes in the same cell as a major factor in relapse. This hypothesis was supported in vitro by the study of the evolution of these co-expressions after incubation with chemotherapy drugs. The current study aims to verify this hypothesis by studying the expression of these genes in single-cell samples from relapsed acute myeloid leukemia patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | blood sampling | Patients will be seen in hospital as part of their routine care, during which a blood test will be prescribed. On this occasion, an additional 20 mlof blood will be collected for research purposes. |
Timeline
- Start date
- 2025-07-31
- Primary completion
- 2028-07-31
- Completion
- 2029-07-31
- First posted
- 2025-04-02
- Last updated
- 2025-04-10
Source: ClinicalTrials.gov record NCT06906978. Inclusion in this directory is not an endorsement.